Financials & Filings

SEC Filings

Filing date Form Description Filing Group View
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML EX-101.INS - XBRL INSTANCE FILE
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML EX-101.INS - XBRL INSTANCE FILE
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML EX-101.INS - XBRL INSTANCE FILE
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML

Data provided by Kaleidoscope.

SEDAR Filing

SEDAR, or the System for Electronic Document Analysis and Retrieval, is a repository of regulatory documents that includes InMed Pharmaceuticals Inc. public filings with the Canadian securities regulatory authorities. To access these documents, visit the SEDAR website.